Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.075 AUD
−24.51 M AUD
33.41 M AUD
136.21 M
About NEXT SCIENCE LIMITED
Sector
Industry
CEO
Harry Thomas Hall
Website
Headquarters
Sydney
Founded
2017
ISIN
AU0000041329
FIGI
BBG00NKWLWT1
Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It operates through the North America, Australia and New Zealand geographical segments. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Sydney, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NXS is 0.120 AUD — it hasn't changed in the past 24 hours. Watch NEXT SCIENCE LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NEXT SCIENCE LIMITED stocks are traded under the ticker NXS.
NXS stock has risen by 9.09% compared to the previous week, the month change is a −14.29% fall, over the last year NEXT SCIENCE LIMITED has showed a −65.22% decrease.
We've gathered analysts' opinions on NEXT SCIENCE LIMITED future price: according to them, NXS price has a max estimate of 0.40 AUD and a min estimate of 0.40 AUD. Watch NXS chart and read a more detailed NEXT SCIENCE LIMITED stock forecast: see what analysts think of NEXT SCIENCE LIMITED and suggest that you do with its stocks.
NXS stock is 0.00% volatile and has beta coefficient of 0.12. Track NEXT SCIENCE LIMITED stock price on the chart and check out the list of the most volatile stocks — is NEXT SCIENCE LIMITED there?
Yes, you can track NEXT SCIENCE LIMITED financials in yearly and quarterly reports right on TradingView.
NEXT SCIENCE LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
NXS earnings for the last half-year are −0.03 AUD per share, whereas the estimation was −0.03 AUD, resulting in a −5.26% surprise. The estimated earnings for the next half-year are −0.03 AUD per share. See more details about NEXT SCIENCE LIMITED earnings.
NEXT SCIENCE LIMITED revenue for the last half-year amounts to 16.86 M AUD, despite the estimated figure of 16.95 M AUD. In the next half-year revenue is expected to reach 26.39 M AUD.
NXS net income for the last half-year is −8.88 M AUD, while the previous report showed −11.74 M AUD of net income which accounts for 24.36% change. Track more NEXT SCIENCE LIMITED financial stats to get the full picture.
No, NXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEXT SCIENCE LIMITED EBITDA is −19.06 M AUD, and current EBITDA margin is −67.24%. See more stats in NEXT SCIENCE LIMITED financial statements.
Like other stocks, NXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXT SCIENCE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXT SCIENCE LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXT SCIENCE LIMITED stock shows the sell signal. See more of NEXT SCIENCE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.